Target Identification : A Challenging Step in Forward Chemical Genetics by Das, Raj Kumar et al.
See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/49610893
Target Identiﬁcation : A Challenging Step in Forward Chemical Genetics
Article  in  Interdisciplinary Bio Central · March 2011
DOI: 10.4051/ibc.2011.3.1.0003 · Source: DOAJ
CITATIONS
7
READS
140
8 authors, including:
Some of the authors of this publication are also working on these related projects:
UCNPs for bio imaging probe development View project
Rapid detection View project
Animesh Samanta
National University of Singapore
42 PUBLICATIONS   1,076 CITATIONS   
SEE PROFILE
Zhai Duanting
National University of Singapore
24 PUBLICATIONS   800 CITATIONS   
SEE PROFILE
Wang Wayne Xu
National University of Singapore
18 PUBLICATIONS   546 CITATIONS   
SEE PROFILE
All content following this page was uploaded by Animesh Samanta on 23 May 2014.
The user has requested enhancement of the downloaded file.
Review 
 
 
Interdisciplinary Bio Central Open Access, Open Review Journal 
 
 
 
www.ibc7.org                                                                                    Volume 3 | Article no. 0003 
Page 1 of 16 
 
Target Identification: A Challenging Step in Forward Chemical 
Genetics 
 
Raj Kumar Das
1
, Animesh Samanta
1
, Krishnakanta Ghosh
2
, Duanting Zhai
2
, Wang Xu
2
, Dongdong Su
2
, 
Cheryl Leong
3
 and Young Tae Chang
1,2,4,* 
1
Department of Chemistry, National University of Singapore, 117543, Singapore 
2
Department of Chemistry & MedChem Program of Life Sciences Institute, National University of Singapore, 117543, 
Singapore 
3
Graduate School for Integrative Sciences and Engineering, National University of Singapore, 119077, Singapore 
4
Singapore Bioimaging Consortium, Agency for Science, Technology and Research (A*STAR), 11 Biopolis Way 138667, 
Singapore
Subject areas: 
Cheminformatics/Chemical biology 
 
Author contribution: R.K.D., A.S., 
K.G., D.Z., W.X., D.S. and C.L. have 
contributed to write the review; Prof. 
Y.T.C. has supervised to the authors. 
 
*Correspondence and requests for 
materials should be addressed to 
Y.T.C. (chmcyt@nus.edu.sg).  
 
Editor: Sun Shim Choi, Kangwon 
National University, Republic of Korea 
 
Received January 21, 2011;  
Accepted January 21, 2011;  
Published January 26, 2011 
 
Citation: Das, R.K., et al. Target 
Identification: A Challenging Step in 
Forward Chemical Genetics. IBC 2011, 
3:3, 1-16.  
doi: 10.4051/ibc.2011.3.1.0003 
 
Funding: The authors gratefully 
acknowledge the National University 
of Singapore (NUS) (Young 
Investigator Award: R-143-000-353-
101) and Singapore Bioimaging 
Consortium, Agency for Science, 
Technology and Research A*STAR, 
Singapore for their financial support. 
 
Competing interest: All authors 
declare no financial or personal 
conflict that could inappropriately bias 
their experiments or writing. 
 
Copyright: This article is licensed 
under a Creative Commons Attribution 
License, which freely allows to 
download, reuse, reprint, modify, 
distribute, and/or copy articles as long 
as a proper citation is given to the 
original authors and sources. 
SYNOPSIS
 
 
Investigation of the genetic functions in complex biological systems is a challenging step 
in recent year. Hence, several valuable and interesting research projects have been 
developed with novel ideas to find out the unknown functions of genes or proteins. To 
validate the applicability of their novel ideas, various approaches are built up. To date, the 
most promising and commonly used approach for discovering the target proteins from 
biological system using small molecule is well known a forward chemical genetics which is 
considered to be more convenient than the classical genetics. Although, the forward 
chemical genetics consists of the three basic components, the target identification is the 
most challenging step to chemical biology researchers. Hence, the diverse target 
identification methods have been developed and adopted to disclose the small molecule 
bound protein. Herein, in this review, we briefly described the first two parts chemical 
toolbox and screening, and then the target identifications in forward chemical genetics are 
thoroughly described along with the illustrative real example case study. In the tabular form, 
the different biological active small molecules which are the successful examples of target 
identifications are accounted in this research review.  
 
 
 
Keywords: chemical toolbox, small molecules, screening, cell imaging, phenotype change, 
genetic information, proteomes 
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Introduction 
 
The completion of Human genome project
1
, has led to the 
discovery of numerous novel genes. However in most cases, their 
functions in dynamic complex biological systems remain unknown. 
Therefore, illuminating the functions of these gene targets and the 
development of mechanistic pathways are poised to be the next 
challenging steps in the field of chemical genetics. Not surprisingly, 
the sheer amount of genetic information now available makes 
analysis a daunting task - a challenge that is currently being 
undertaken by the field of functional genomics
2
. The significant gap 
of functional genomics after identification of new pathways
3,4
 and 
networks can be filled up by the emerging concept of chemical 
genetics
5
. Depending on the starting point of investigation, chemical 
genetics can be divided into two approaches
6
: forward chemical 
genetics
7
 and reverse chemical genetics
8
, which proceed “from 
effect to cause” and “from cause to effect”, or “from phenotype to 
genotype” and “from genotype to phenotype”
9
 respectively. 
Screening small-molecule libraries
10
,
11
 for compounds that generate 
a phenotype of interest is an example of the forward chemical 
genetic approach whereas the reverse approach entails small 
molecules that target a single protein. Contrary to conventional 
genetics where gene knock-outs
12
 or overexpression
13
 are carried 
out, forward chemical genetics exploits the small-molecules to 
generate new phenotypes that are utilized in the explication of gene 
functions. Forward chemical genetics requires three basic 
components: a) a chemically diverse library of compounds; b) an 
assay, in which the library is screened for a cellular
14
 or 
organismal
15
; phenotype and c) a method to trace an active 
compound to its biological target - otherwise known as target 
identification. It is this third component - target identification that 
remains one of the greatest challenges in chemical genetics. 
 
 
Merit of Forward Chemical Genetics 
 
In recent years, chemical genetics has increased in popularity 
due to the inducing capability of small molecules to modulate 
biological activity in reversible ways
16
. Although genetics can be 
applied for a better understanding of complex biological systems 
based on their capacity to modulate biological activity to a high 
degree of specificity, it does have its limitations. Direct induction of 
genes by sensitive mutation often raises the complicated situation 
to identify the effect of modulating gene products
17
. In genetics, 
delivery of gene is the most vital problem due to the issue of cell 
permeability. The generation of mutants one by one is also a 
tedious and time-consuming process. In mutation of genes, the 
importance of post translational modification or protein functions is 
not considered. Moreover, in mutation of genes, it is not feasible to 
confirm the reliable target for drugs and the over all process is also 
slow. In most cases, one protein has multiple functions, thus their 
modification (e.g. knockdown) does not lead to the expected effects. 
Moreover, other genetic methods, like antisense technology
18
, 
mutagenesis or RNAi interference can be applicable at the level of 
the genes which cause some temporal or even permanent effects. 
 
Keeping in mind these issues in genetics, small molecule induced 
chemical genetics especially forward chemical genetics has several 
advantages. For example, the biological effect of small molecules is 
typically rapid
19
 and it allows for characterizing the instantaneous 
effects of small molecules. Moreover, all small molecules can be 
used to study the dynamic processes in a conditional manner
20
. For 
example, they can be applied at any time point in the experiment 
conditions with different concentration range to study critical genes 
at any developmental stage. Small molecules can also be used in 
multi cellular organisms
21
 to see the phenotypic change in vivo 
systems. A successful forward genetic study offers the knowledge 
about a novel gene's function as well as a small molecule which has 
the potential to serve as an on/off switch to control biological 
processes
22
. Therefore, these small molecules can be useful 
biologic probes as well as potential new drug candidates. 
 
 
Devices for Forward Chemical Genetics 
 
1. Chemical toolbox 
In the last few decades, various inventive chemical toolboxes 
have been developed for the study of numerous gene functions in 
system biology. The chemical genomics field is rapidly expanding 
and evolving to facilitate the discovery of different unknown 
functions of genes by the aid of chemical toolboxes
23
. Inspired by 
many successful attempts, research groups are racing to invent 
novel and effective functions of gene networks by applying diverse 
chemicals libraries. Identifying these new networks would 
significantly enhance the discovery of new drug molecules from this 
powerful chemical toolbox. This powerful technology, known as 
“chemical genomics” not only overcomes significant gaps in 
functional genomics but also has the potential for the discovery of 
novel drug-like small molecules. These small molecules which can 
be found from large libraries of compounds from different sources 
generally alter the functions of proteins after binding to the target 
proteins. The compounds are derived from natural plant
24
 and 
animal sources subsequent extracted and synthesized into small 
molecules.  
 
1a. The discovery of bioactive compounds  
In system biology it is more interesting to choose the suitable 
novel chemical entities which are capable of modulating biological 
functions after binding to the target proteins. This unknown protein 
function is influenced by diverse drug-like small molecules which 
can be found from different commercial sources
25
 such as 
ChemBridge Corporation, Maybridge Chemical, Thermo-Fisher Hit-
Finder, ChemBridge MicroFormats, and Spectrum Collection etc.  
 
1b. Combinatorial libraries 
The large amount of chemical compounds can be synthesized in 
the laboratory by using basic scaffolds which may belong to 
different classes such as heterocycles, natural products, 
oligosaccharides, and fluorochromes. By applying the diversity-
oriented design strategy
26
, large collections of structurally diverse 
and complex compound sets are synthesized through parallel and 
mixture synthesis of small molecules by combinatorial chemistry. 
The approach is that a library with the same core scaffold, but with 
various diversity elements/branches directly attached around the 
core, may selectively respond to a broader range of analytes and 
thus show a greater likelihood to “hit” the target
27
. Numerous 
methods are available for creating such diversity, such as skeletal 
diversity
28,29
, stereochemical diversity, and molecular property 
diversity
30,31
.  
 
1c. Natural product-like libraries 
Natural products are considered as a vast source of chemical 
compounds by most industrial drug research organization where 
they widely utilized, explored and modified to construct better 
derivatives
32
. Many biologically validated drug developers would 
choose to generate libraries from natural product cores, which are 
in a way sensible and effective
33-35
.  
 
1d. Heterocyclic libraries 
The majority of the heterocyclic compounds are widespread in 
various protein networks in the cellular context and built up for many 
cofactors of enzyme substrates, and also available as the main 
component of the DNA such as purine, pyrimidine bases. Hence, 
these are the highly desired structures for the development of new 
drug like small molecules
36
. In heterocyclic chemistry, cycloaddition 
and multicomponent reactions (MCRs) are mainly applied to 
construct a complex heterocyclic library
37
 in DOS with different 
substitution. The number of hydrogen bond acceptors and donors in 
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heterocylic compounds are higher than normal chemicals and most 
of the time accomplishes the appropriate balance of hydrophilic and 
lipophilic characters which is suitable for bioavailability and 
membrane-permeability. 
 
1e. Oligosaccharides libraries 
The oligosaccharides are the main components of the 
glycoproteins and are known to be the extracellular segments of 
integral membrane proteins. These are attached with compatible 
amino acid chains in proteins or lipid moieties. The different 
structures and distribution of these oligosaccharides are 
responsible for the cell regulation and their several respective gene 
functions
38
. Diversity of the oligosaccharides part increases the 
chance of interactions between the receptor and target analytes. 
  
1f. Peptide libraries 
The development of solid phase synthesis by Merrifield in 1963 
and the discovery of the different functional groups protection 
methods led to the rapid design of different peptide libraries. 
Generally, the standard Fmoc protected aminoacids are used to 
make a peptides library by using either modern microwave assisted 
coupling with low cost coupling reagents or even utilizing the more 
sophisticated mechanical peptide synthesizer in a very short time 
frame. After completing the reactions, all peptides are cleaved and 
purified by HPLC. This peptide library can be further functionalized 
by different linkers to incorporate the fluorochromes for specific 
applications for in vitro cell analysis or in vivo experiments
39
.  
 
2. High-Throughput Screenings  
Phenotypic screenings are one of the most vital steps in forward 
chemical genetics study where high throughput screening is widely 
utilized to explore new biological active compounds. The active 
compounds show phenotype change mainly by changing protein 
(small molecule bind protein) function. The (high throughput) 
screening with small molecules is carried out mostly by use of 
model organism, mammalian cells or cell free systems. The most 
popular model organisms reported for phenotypic screening are 
yeast, plants, zebrafish, Drosophila and C. Elegans. Two types of 
yeast
40
 (budding and fission yeast) are used. Yeast is applied for 
screening because of its easy growth, high genetic conservation 
with human and known genome sequence. Plants
41
 are also 
commonly used (e.g. Arabidopsis thaliana) as the entire genome 
has been sequenced, and small molecules are readily up taken by 
plant roots. Drosophila
42
 is sometimes used for screening for its 
short life cycle, known genome sequence and RNAi. Zebrafish
43
 are 
widely used because it is vertebrate (having brain, heart, bone) and 
hence comparable to the human vertebrate system. They are also 
prolific reproducers, transparent and thus easy to visualize when 
observing phenotypic change. The use of C. Elegans
44
 for the 
screening is also commonly reported. Its short life span, small and 
transparent appearance, known genome sequence and RNAi make 
it a useful model organism. 
 
Recent technological advancements in liquid handling and 
robotics have also facilitated the development of high throughput 
screening of several individual compounds in a very short time. The 
screening is executed by exploiting living cells (mammalian cell), or 
complex cellular extracts. The cell phenotype can be simply and 
swiftly determined by the recent use of ELISA
45 
(cytoblot) method. 
The compounds treated cells are appended and stained by the 
antibody to an epitope which speculates the phenotype of interest. 
Secondary antibody conjugated to horseradish peroxidase is 
normally put in to find the signal as a luminescence. 
 
„Screening by imaging‟
46
 has recently appeared as an advanced 
technique whereby an automated microscope is employed to 
observe and record cellular phenotype change in response to 
compound addition. The screening is carried out in multi well plates 
and the generated data is analysed by the software. Fluorescence 
spectroscopy
47
 and transmitted light microscopy
48
 are also routinely 
used to perform the phenotypic screen. 
 
3. Target Identification Approaches 
Drug discovery research requires wide knowledge of disease-
related proteins and their functions and the forward chemical 
genetics approach robustly contributes to this field by identifying the 
target proteins which bind to the small molecules. Once the proteins 
are identified, their functions and cellular signalling pathways can 
be elucidated thereby facilitating drug discovery research. However, 
exisiting methods for target identification such as affinity matrix 
have met with limited success. Many researchers encounter 
difficulty when investigating protein targets as most of the time the 
protein of interest is expressed at levels that are too low in 
biological systems for effective detection. Low binding affinity to the 
small molecules as well as non-specific binding also make up some 
of the many problems that plague the field of target identification 
research. To circumvent the problem, many researchers have come 
up with advanced methods through the use of small molecules to 
identify and discover new protein targets. 
 
3.1. Affinity matrix approaches 
One of the most powerful techniques to identify a target protein is 
the affinity matrix approach
26
. The affinity matrix can be achieved by 
modifying the hit compound on a bead or by attaching a tagged 
molecule (photoaffinity, chemical affinity, biotin or fluorescence). In 
each case, the binding affinity of the proteins with small molecules 
is utilized to find the target proteins
49
. After binding the small 
molecules with the proteins, the respective complexes are fished 
out by immobilizing small molecule
50
 and can be identified by gel 
separation (SDS-PAGE or fluorescence gel) followed by MS-MS 
(tandem mass-spectrometry). 
 
3.1a. On-bead affinity matrix  
In this approach, structure-affinity relationship (SAR) has to be 
first studied for a small-molecule of interest in order to find out the 
proper position for suitable linker modification. Second a solid-
phase matrix (agarose beads) has to be attached covalently to the 
small molecules in a specific site which does not affect the original 
activity of interest of the small molecule
17
. Furthermore, the resin 
bound small molecules are exposed to cell extract to separate the 
target protein. SDS-PAGE gel chromatography is applied to analyze 
the proteins mixtures which are immobilized through the column. 
The specific target proteins are isolated by competition assay that 
assists to exclude the non specific binders. The isolated proteins 
are identiﬁed by mass spectrometry after partial tryptic digestion 
and database searched for mass-sequencing of the digested 
peptides. The result would be the discovery of target proteins or 
genes. 
 
 
[Case study]  
The high throughput screening of library molecules for finding the 
brain/eye morphological changes in the zebrafish embryo assay 
revealed that the encephalazine can inhibit the brain/eye 
development up to the different time point (1,8, and 1K cell stages). 
After the SAR study, the encephalaizine compound was attached 
with the agarose beads and then used for finding the target protein. 
 
 
 
Figure 1. Schematic representation of affinity matrix: on bead for 
target identification. 
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Affinity matrix based pull down experiment followed by 14% SDS-
PAGE resolved and silver staining identified the two strong bands 
(23 and 18 kDa) to be ribosomal protein
49
 (S5, S13, S18, and L28) 
which was further confirmed by LC-MS/MS . 
 
 
3.1b. Biotin tags in affinity matrix 
The strategy of finding target proteins using biotin based affinity 
matrix is regularly used in chemical biology. After rigorous SARs 
study, the biologically active biotin attached small molecules are 
developed which are then treated to the cell extracts containing 
proteomes
51
. Next, the small molecule-biotin-protein complex can 
be fished out by using avidin/streptavidin resin beads
52
 and then the 
corresponding target protein (after cleaved from the resin) can be 
identified by gel running followed by mass spectrometry analysis. 
 
 
[Case study]  
Image based high throughput screening of ESCs (R1 cell line) 
identified the small molecule straupimide which interacts with the 
NME2 protein and inhibits its nuclear localization, subsequently, the 
efficiency of the ESCs (human and mouse) differentiation increased. 
Stauprimide promotes ESCs differentiation toward the definitive 
endoderm fate which was confirmed by cell image experiment using 
various markers (definitive endoderm specific, mesoderm specific, 
visceral/parietal endoderm specific) and with the RT-PCR 
experiment using hepatocytes and pancreatic precursors cells ( Afp, 
albumin, Cyp7A1, Pdx1, Ngn3 cells). The 
results obtained from both the experiments 
indicate that the stauprimide promotes the 
definitive endoderm mediated ESCs 
differentiation. Using biotin tagged affinity 
based approach to precipitate out the target 
protein followed by mass spectrometry 
confirmed the NME2 protein as a cellular 
target of the stauprimide small molecule
53
. 
The in vitro experiment and gene knock 
down experiment (KD1 and KD2 genes 
sequences), further confirmed that the 
NME2 protein is the cellular target of the 
straupimide small molecule. 
 
3.1c. Fluorescent tags in affinity matrix  
Sometimes, affinity matrix with fluorescence tag can be used to 
visualize a target protein quite easily. The approach is quite similar 
to the biotin tag approach. In the case of fluorescence tag approach, 
small molecule bound proteins can be recognized by running 
fluorescence gels. The visualized fluorescence bands are excised 
and then analyzed by mass spectrometry to identify target proteins. 
 
[Case study]  
Cell (MDA-MB-231 human breast cancer cell) based screening of 
50-membered natural product-like library revealed the compound 
MJE3, which can inhibit breast cancer cell proliferation (IC50 value 
of 19 M) and then activity based protein profiling (ABPP) which is 
quite similar like affinity matrix contained a reactive group, a binding 
group and an analytical tag. In this study a fluorescence tag was 
employed for successful identification of the target protein. After 
incubating the MJE3 in the MDA-MB-231 cells, the click reaction 
was carried out between the MJE3 labeled protein with a 
trifunctional biotin/rhodamine-azide reporter tag and the probe 
labeled protein was separated in SDS-PAGE and then visualized in 
gel fluorescence scanning
25
. The probe labeled protein was 
subsequently purified using avidin agarose beads. The gel band 
(26-kDa) was excised and 
then after the trypsin 
digestion the resulting 
peptide mixtures were 
analyzed and the MS data 
based search identified 
the 26-kDa protein as 
brain-type 
phosphorglycerate 
mutase 1 (PGAM1). 
 
3.1d. Photoaffinity tags in affinity matrix  
In this method, one photoaffinity moiety along with a reporter tag 
is added to the initial molecule (hit compound), making it highly 
reactive upon UV irradiation, releasing a reactive carbene functional 
group that can covalently attach to the specific target proteins. 
Subsequently, this binding protein can be fished out from the 
complex by a biological cell assay
54
. The reporter tag is usually a 
radioactive isotope
55
 or chemical affinity group such as biotin, which 
allows for isolation and identification
8
. Mainly stable isotopes that 
can give unique isotopic pattern have been used to selectively 
identify the binding proteins even in very complex mixtures by mass 
spectrometry. 
[Case study]  
Image based high throughput phenotypic screening of 
neuropathiazols compounds identified some compounds which 
induce neuronal differentiation of cultured rat hippocampal NPCs. 
Synthesis of several analogs of the original neuro-pathiazol 
structure and a focused structure-activity relationship (SAR) study 
afforded a molecule (KHS101) of best activity towards the neuronal 
differentiation. The RT-PCR experiment and image based 
experiment revealed that the treatment of KHS101 significantly 
suppresses astrogenesis and at the same time it increases the 
neurogenesis. Protein-KHS101-BPcomplex was detected after 
 
 
 
 
Figure 2. Schematic representation of affinity matrix: biotin tagged 
target identification method. 
 
 
Figure 3. Schematic representation of affinity matrix: fluorescence 
tagged target identification method. 
 
 
 
 
 
Figure 4. Schematic representation of the affinity matrix: 
photoaffinity based target identification method. 
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photocrosslinking and biotin-tag labeling by using two dimensional 
SDS/PAGE and western blotting of NPC cell lysates. Finally, mass 
spectrometry analysis revealed 
the 80-kDa protein to be 
TACC3. Gene knock down 
experiments and in vivo 
imaging studies confirmed that 
the TACC3 protein is the 
cellular target of the KHS101 
small molecule
27,56
. 
 
3.2. Drug western approaches 
In the Drug westerns method
57
, bacteriophages are grown in a 
petridish. Then the lysis caused by a viral infection can lead to a 
clearing, consisting of one member of the library. The proteins from 
the plaque are moved to the nitrocellulose and then these are 
screened against the tagged small molecules. Hit obtained from the 
plaques are isolated and then each single virus is purified and 
followed by the application of the DNA sequencing method, the 
each target protein is identified. 
[Case study]  
Cell based screening of sulfonamide drug molecules, followed by 
SARs study found the small molecule HMN-154 which showed the 
potential anticancer activity towards the various cancer cell lines. 
The HMN-154 coupled BSA tagged was employed to identify the 
target protein using the drug-western method. BSA-conjugated 
HMN-154 was incubated in nitrocellulose membrane where the 
protein was expressed by the lTriplEx cDNA 
library. The positive clone, expressing HMN-
154-binding protein was detected
57
 and then 
the binding protein was identified after the 
DNA sequencing study to be transcription 
factor inhibitor NF-YB. The identified protein 
was further confirmed by an in vitro inhibition 
assay and immune-precipitation experiments. 
 
3.3. Three-hybrid system approaches 
So far, two types of three hybrid systems have been developed in 
order to identify target proteins. Yeast three hybrid systems are 
performed in yeast cells, and mammalian three hybrid systems are 
carried out mammalian but both the approaches are quite similar. 
Initially, both the systems were used to study the protein- protein 
interaction, but later the applications were widened to study the 
small molecule-protein interactions too. 
 
3.3a. Yeast three-hybrid systems 
The yeast three-hybrid system (Y3H) is evolved from yeast two-
hybrid screens and incorporates a dimer of organic small molecules 
into the screening spot. It comprises of three components: a 
synthetic hybrid ligand and two hybrid fusion proteins. The synthetic 
hybrid ligand is formed by covalently linking two small molecule 
ligands (hetero/homodimer) which induces cellular proteins in 
different cells. The synthetic hybrid ligand remains attached to one 
of the two hybrid fusion proteins. One of the small molecules in 
hybrid ligand brings the third hybrid protein to close constituting a 
functional transcription factor that drives expression of a reporter 
gene
58
. Whereas first ligand of the dimer binds to the receptor of 
DNA-binding domain, a second ligand binds to the receptor of 
transactivation domain allowing for the selection of yeast cells that 
harbor the relevant receptors. The two functions (ligand–receptor 
interaction) of the system are screened by the small molecule 
dimers with a known activation domain or using a known small 
molecule to identify target proteins, such as dexamethasone-
glucocorticoid receptor to find interacting proteins. The advantages 
of Y3H system is that it is carried out in vivo thus the phenotype and 
genotype are closely linked. On other hand it is restricted in a 
unicellular system. 
[Case study]  
Cell based CDK (Cyclin Dependent Kinase) inhibition assays and 
a purine library screen, followed by SARs study discovered a small 
molecule named Purvalanol B which can inhibit cyclin dependent 
kinase activity in human leukemic cell at a nanomolar concentration 
range. In order to identify the target protein, Yeast three hybrid 
cDNA libraries screening employing small molecule Purvalanol B-
MFC (methotrexate fusion compound coupled with the Purvalanol 
B) was pursued by utilizing the following steps. First, the lexA-DHFR 
expressing yeast cells were transformed with the choice of cDNA 
library. Next, transcriptional expression of the HIS3 auxotrophic 
marker was selected in the presence of an MFC. Then, the positive 
colonies were picked up and arrayed robotically; following this the 
compound dependence to the HIS3- reporter expression was 
reconfirmed. Finally, plasmid isolation, sequencing, retransformation 
of yeast expressing LexA-DHFR with purified plasmids, robotic 
arraying of the transformed yeast cells and reconfirmation of 
specific HIS3-reporter activation by the test MFC using a series of 
genetic or compound-based counter 
screens identified small molecule 
binding target proteins
58
 (CDK1, 
CDK5, CDK6, CLK3, EPHB2, FLT4, 
FYN, PAK4, PCTK1, PCTK2, RSK3 
and YES), many of which were further 
confirmed by using the affinity matrix 
pull down experiment and secondary 
enzyme assays. 
 
3.3b. Mammalian three-hybrid systems 
The mammalian three hybrid system is similar to the yeast three 
hybrid systems where mammalian cells are used instead of yeast. 
Initially, S. Eyckerman, et al developed the MAPPIT
59
 explain 
acronym system in order to identify protein-protein interactions. 
Later C. Maureen, et al expanded this concept to the MASPIT
60
 
system to investigate small molecule-protein interaction and target 
identification. 
 
[Case study]  
After the synthesis of the several small molecules of Pyrido [2,3-
d] pyrimidine, followed by their application in the kinase inhibition 
assay and SARs, studies revealed PD17395 as a SRC kinase 
inhibitor which can inhibit several ephrin receptor tyrosine kinases. 
In order to identify the target protein, the MASPIT system was 
employed in mammalian cells. For target identification, the following 
pathways were adapted as l in Y3H. First, a cDNA library was built 
up from HEK293 mRNA in a retroviral vector and then the IL5R 
reporter cells were infected with the retroviral library and subjected 
to various cycles of enrichment for MFC-dependent IL5R-positive 
cells, followed by ﬂow cytometric single-cell sorting into 96-
wellmicro-titer plates. Individual cell populations were subsequently 
screened for MFC and Epo-dependent reporter activation by 
ﬂuorescence activated cell sorting (FACS). The cDNA library screen 
 
 
 
 
Figure 5. Schematic representation of the drug western techniques 
for target identifiaction. 
 
 
 
 
 
 
Figure 6. Schematic diagram of Y3H system for target identification. 
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with RGB-286649 and the MFC incorporating the ABL tyrosine 
kinase inhibitor PD173955 discovered a number of different 
tyrosine kinases as well as one Ser/Thr kinase (Cyclin G-
associated kinase, ephrin 
receptor tyrosine kinases, FGFR1 
and SRC kinases FYN and 
LYN)
60
. These proteins were 
further confirmed with the in vitro 
enzymatic assay (competition 
assay). 
 
3.4. Phage display approaches 
In recent years, phage display technology has emerged as a 
popular method to connect proteins or polypeptides with genes in 
bacteriophages to study the protein-protein, protein-DNA and 
protein-peptide interactions. This technology utilized the display of 
proteins or peptides on bacteriophages such as filamentous, M13, 
T4, T7, phage and it enables the extraction of proteins from a large 
collection of variants by immobilizing relevant DNA or proteins. The 
resulting phage particles containing genes and encoded proteins 
provide a connection between phenotype and genotype that 
enables large libraries of proteins to be screened and further 
amplified. In the process of screening, the bacteriophage displayed 
protein bound to the target will remain in the washing step and other 
non interacting proteins are removed. The recovered proteins are 
identified by sequencing and more phages can be produced by 
bacterial infection to enrich the interacting proteins for further 
selection
61
. 
[Case study]  
Screening of a library of 1200 compounds revealed a candidate, 
IHY-153 that can effectively inhibit the proliferation of several human 
cancer cell lines, including human Cervical Cancer cell line (HeLa), 
human liver carcinoma cell line (HepG2), human fibrosarcoma cell 
line (HT 1080) and human colon carcinoma cell line (HCT116). 
Among them, HCT116 colon cancer cells are the most sensitive to 
IHY-153. Investigation of the effect of IHY-153 on HCT116 cell cycle 
progression by flow cytometry indicates that IHY-153 inhibits cell-
cycle in a dose-dependent manner and induces cell cycle arrest at 
G0-G1 phase. Bacteriophage display biopanning approach was 
applied in the target identification. T7 phage particles expressing 
human cDNA libraries were added into the BH1-immobilized wells. 
After incubation and washing, bound phage particles were eluted 
with 1HY-153 and eluted phage particles were amplified after 
infection into E. coli strain BLT5615 and used for a second round of 
biopanning. After the fourth biopanning, eluted phages were 
infected into LB agar E. coli and plaques formed were isolated. 
Amplified phage lysates from the isolated plaques were used as 
PCR templates and obtained sequences were compared with 
database. The phage encoding 
region matched 100% with human 
calmodulin (CaM). The specificity 
of IHY-153 towards CaM was also 
tested via phage binding assay 
and phage library. Necessity of 
Ca2
+
 for CaM binding with IHY-
153 is tested and results 
demonstrate that Ca2
+
 is required 
for IHY-153 binding to CaM
61
. 
 
3.5. mRNA display approaches 
mRNA display is an well known in vitro technique and has 
recently been used in studying protein-protein interaction
62
. The 
technique was initially developed to amplify the number of 
peptides
63
 displayed in the phage display method. After the cDNA 
library amplification by PCR, the puromycin–DNA linker is ligated to 
the produced mRNA and using this mRNA-DNA complex
64
 in vitro 
translation is carried out. The translation leads to generation of 
mRNA-protein fusion molecules which are then purified and reverse 
transcribed to generate the cDNA template which can be utilized to 
construct further amplification. Then the small molecules of interest 
are immobilized on solid support and are incubated with mRNA 
display molecules. The unbound protein-mRNA complexes are 
washed out and bound complexes are eluted and the bound genes 
amplified using PCR technique. Finally, after the several iteration 
processes, the cDNAs are purified, cloned, sequenced and put 
thorough a sequence similarity search to identify the target protein. 
[Case study]  
Tacrolimus (FK-506)
65
 is a natural product which is established to 
be an immune-osuppressive drug. Molecules bound to the target 
protein were identified by using FK-506 biotinylated compounds in 
mRNA display method. After making the biotin tag with the FK-506, 
several steps are carried out in order to identify the molecular target 
in the mRNA display method.  
 
In the beginning, the PCR-amplified cDNA was generated by 
applying primers that commence the engineered sequences 
necessary for transcription, ligation of the corresponding mRNA, in 
vitro translation of the mRNA-puromycin linker conjugate, and 
 
 
 
 
Figure 8. Schematic representation of mRNA display techniques for 
identifying target protein.  
 
 
 
Figure 7. Schematic diagram of phase display method for 
identifying target protein. 
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epitope-based purification of the mRNA-protein fusion, Then this 
engineered PCR product was transcribed to construct mRNA which 
was then hybridized to a poly-dA-containing linker carrying a 5‟-
psoralenmoiety and a 3‟- terminus containing the transfer-RNA 
mimic puromycin (Pu). Next a covalent crosslink between the 
mRNA and DNA-puromycin linker was introduced upon UV 
irradiation and this conjugate (mRNA-DNA-puromycin) was 
employed as a template for in vitro translation where ribosome 
could translate the open reading frame and stop at the mRNA-DNA 
junction. The dearth of a stop codon hindered the action of release 
factors and permitted the conjugate puromycin to enter the A-site of 
the ribosome and then the peptidyl transferase subunit catalyzes 
amide bond formation between an amine group on the puromycin 
and the carboxyl terminus of the mature protein to give an mRNA-
protein fusion. Next, the fusion was purified (dissociation from the 
ribosome happened in presence of poly dA linker with oligo-dT 
cellulose) and the cDNA strand was made by reverse transcription 
of the fusion that protected the mRNA against degradation and 
served as a template for future PCR. After the initial random priming 
of cellular mRNA, the library of mRNA display molecules were then 
incubated with an immobilized 
drug (immobilized on streptavidin 
bead) or small molecule, and 
unbound material was eliminated 
by washing. The bound fusion 
protein was then eluted either 
specifically using excess of drug 
or nonspecifically using KOH. 
The identified target protein was 
found to be FKBP12
51
. This was 
further confirmed with the in vitro 
protein binding assay. 
 
3.6. Protein microarray approaches 
The high throughput analysis of interactions between the target 
proteins and small molecules can be performed by using protein 
chip technology which is known as protein microarray
66
. The high 
density format is used in this approach. Hence, only few days are 
required to study the binding profile of a certain small molecule to 
an entire proteome. The proteins of interest for analysis are purified 
and consequently immobilized on the glass microscope slide or 
derivatized on another surface
67,68
. The fluorescent tag or 
radioisotope-labeled small molecules are incubated in the array and 
then the positions where small molecule binds protein on the array 
are determined and the target protein subsequently identified. 
[Case study]  
Yeast growth inhibition studies using the chemical genetic screen 
of small molecules (16,320 compounds) identified SMIR3 and 
SMIR4 which can fully suppress rapamycin‟s anti-proliferative 
effects in yeast. Both the molecules were then biotinylated (to 
preserve their bioactivity) to identify target protein.  
Biotin-small molecules (SMIR3-biotin and SMIR4-biotin) were 
probed on the proteome chip which consisted of almost the entire 
yeast proteome. After adding Cy3 labeled streptavidin on the 
proteome chip, 8 different candidate proteins binding to SMIR3-
biotin and 30 different candidate proteins binding to SMIR4-bioitin 
were identified. This was followed by an in vivo study of rapamycin 
sensitivity and the ability of SMIR to suppress the rapamycins‟s 
effect towards the yeast cell using the yeast deletion strain of each 
candidate protein (found by protein chip) discovered 
YBR077CP(Nir1P) protein which is responsible for SMIR4 to 
suppress rapamycins‟s effect
69
. 
 
3.7. Drug affinity responsive target stability (DARTS)  
A few successful cases have been reported based on the affinity 
matrix method. Introducing an affinity tags on to effective drug 
molecules to identify the target proteins is a major challenge due to 
the present limitations. A new technique, drug affinity responsive 
target stability (DARTS) may have great prospective to discover 
target proteins by stabilizing the target protein upon the binding of 
drug like mall molecules
70,71
. This modern methodology represents a 
target identification strategy without the modification of small 
molecules and relies on drug–protein binding. After binding with 
drug molecules, target proteins are less susceptible towards 
proteolysis thus helping to readily identify target proteins even in 
complex biological systems. Generally the ligand-bound states are 
thermodynamically favourable structures among multiple dynamic 
conformations due to hydrogen bonding, hydrophobic and/or 
electrostatic interactions between the protein and the small 
molecules. Hence, the target proteins are stabilized by restricting 
the multiple conformations. 
 
To date the affinity matrix as well as affinity chromatography 
methods are well studied by different research groups and its major 
limitations are well defined. In spite of several good examples 
having been reported, the major drawbacks (e.g. nonspecific 
binding to nontarget proteins, time consuming SAR study and 
impossible to incorporate the affinity tag for some drug like small 
molecules) limit its application. In general, nonspecific binding 
proteins can be eliminated by simple washing for multiple times but 
in the same time interested binding proteins may be eliminated if 
the interaction between target proteins and small molecules is too 
weak. Therefore, compared to affinity matrix, DARTs presents a 
unique alternative path that allows for the detection of the target 
proteins by small molecules which requires neither further chemical 
derivatization nor extensive washing. Furthermore, this approach 
allows all bioactive small molecules, different source of extensive 
chemical library with diverse structural diversity including natural 
products too. DARTS apply to find target proteins from complex 
biological samples by digesting away nontarget proteins that are 
 
 
 
Figure 9. Schematic representation of protein microarray method 
for target identification. 
 
 
 
 
 
 
 
 
Figure 10. Schematic representation of DARTS principle. 
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susceptible to protease hydrolysis and vice versa. 
 
[Case study]  
Resveratrol, a compound that can be found in grapes and red 
wine is known to be responsible for various health benefits. 
However, its direct molecular target protein has not been reported 
so far due to low specific binding affinity of small molecules towards 
proteins. A potential requirement of the polyphenol groups in 
resveratrol for its activity has discouraged generation of affinity 
reagents for target identification. To overcome this limitation, 
Lomenick et al, came up with a novel idea considering the less 
susceptibility of the target protein to drug binding named as drug 
affinity responsive target stability (DARTS). As a proof of principle 
small molecule-protein complexes (mTOR-rapamycin and COX-2–
celecoxib) are identified by DARTS method. Eventually, a target 
protein eIF4A was identified by applying new tools (DARTS). 
DARTS with resveratrol dosed yeast cell lysates revealed two silver 
stained bands between the 15- and 20-kDa MW markers that were 
more intense in the resveratrol 
treated lysate post proteolysis 
compared with the control. Mass 
spectrometry analysis identified 
the target protein as eIF4A
70
. 
Further gene mutation of target 
protein clearly depicts that eIF4A 
is the vital protein for various 
health benefits. 
 
3.8. In vitro inhibition assay: guess and check method 
Sometimes, the target protein could be determined by using a 
simple in vitro assay. After the detection of a hit compound by 
looking at the change in the cell or organismal phenotype or by 
looking at the cell images, expert researchers can predict some 
relative target proteins responsible for the respective alternations. 
This knowledge based approach leads one to guess and then to 
check some in vitro assay with some presumed proteins thereby 
leading to the identification of target proteins. This is a frequently 
used method
36
 to find out the target proteins.  
 
[Case study]  
Optical density based high throughput screening of conditionally 
essential enzymes identified a small molecule which can prevent 
the growth of a wild type bacterial strain but do not affect the growth 
of a mutant strain incapable of initiating polymer synthesis. This 
approach led to the discovery of 1835F03
72
, a molecule that can 
inhibit the wall teichoic acid (WTA) biosynthesis in Staphylococcus 
aureus. Using radiometric in vitro assays to 
test the inhibitory effects of 1835F03 on Tar 
B,D,F and L, and using overexpression 
and resistant mutants analysis showed that 
the 1835F03 compound can potentially 
inhibit the function of the TarG, which can 
exports WTAs to the cell surface, with an 
MIC of 1.3 µg/mL. The assessment of the 
antibacterial properties of 1835F03 
compound can clearly demonstrate that its 
activity was fully bacteriostatic. 
 
3.9. Magnetism-based Interaction Capture (MAGIC) 
Magnetism-based interaction capture (MAGIC)
73,74 
is an in vivo 
target identification approach in mammalian cells. The compound 
specific for target proteins is bound to cDNA library coupled with 
EGFP motif. When proteins are attached to the compounds, they  
 
will be separated from matrix under magnetic field. Hence through 
this magnetism-based approach the target protein can be extracted 
out and identified. 
 
[Case study]  
The magnetism-based interaction capture (MAGIC) method was 
first developed by the Korean scientist (Jaejoon Won and his 
coworkers) in science journal
73
 to identify target protein in living cell. 
High throughput screening revealed the ATM protein as the cellular 
target of the small molecule CGK733
74
. However, both the journals 
were retracted for data fabrications and results misrepresentation. 
Hence, there is no real example of target protein identification in 
this approach, although this method may be a good potential to find 
out the target protein in complex system.  
  
In above study, we have demonstrated different useful strategies 
for the target protein identifications in complex biological systems. 
Moreover, we also highlighted the potential application of these 
strategies in forward chemical genetics with specific real examples. 
In the below table we have summarized several examples in a short 
and succinct way for better understanding (Table 1). 
 
 
Conclusion and Prospects 
 
In this review, we described all the three components of forward 
chemical genetics. The approach consists of the collection of 
chemical compounds from various sources, screening in a high 
throughput format and then the daunting task of target identification. 
The first two parts were covered briefly and then we mainly focused 
on the several target identification methods with successful story of 
discovering small molecules bound proteins. Our objective in this 
review is to bring most of the target identification methods which are 
successful for identifying target proteins into one frame. Previously 
most routinely used methods like affinity matrix and other protocols 
sometimes show hurdle to discover target proteins. To resolve the 
problem, more technically advanced target identification methods 
have been steadily developed in the recent years. Our review has 
included both the previous and recent target identification protocols 
along with illustrations of several real examples which were 
accumulated from several research works. Hence, chemical biology 
researchers can easily follow as well as apply any target 
identification method in their respective drug discovery research. 
We prognosticate that this review would be supportive for the 
researcher to employ forward chemical genetics in accelerating the 
drug discovery research. 
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Figure 11. Schematic representation of MAGIC method for target 
identification. 
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Table 1. Representative examples of successful target identification approaches 
Small molecule Library size Activity Target protein 
Target identification 
methods 
Reference 
K858 
 
Single molecule 
Inhibit the ATPase 
activity of Eg5 
Eg5 
Guess and check 
method 
75 
Withaferin A(WFA) 
 
Not specified 
Antitumor and 
antiangiogenesis 
activity in vivo 
Type (III) intermediate fila
ment (IF) protein, vimentin. 
Affinity matrix: 
biotin tag 
33 
Epolactaene 
 
Singles molecule 
Inhibited mammalian 
DNA polymerases 
and human DNA 
topoisomerase II 
in vitro 
Hsp 
(heatshock protein) 60 
Affinity matrix: 
biotin tag 
76 
MOL 249 
 
Not specified NF-κB inhibition Thioredoxin 
Guess and check 
method 
77 
Small molecule 
inhibitors of rapamycin 
(SMIR4) 
 
16,320 
Inhibition of 
rapamycin activity 
Tep1p and Ybr077cp  
(Nir1p) 
Protein microarrays 69 
Splitomicin 
 
 
6,000 
Yeast growth 
inhibition 
Sir2p 
Guess and check 
method 
78 
SFK1 
 
 
100,000 Suppressor of FK506 Por1p 
Affinity matrix: 
on bead 
79 
SFK2,3,4 
 
 
100,000 
Suppression of FK506 
activity 
Ald6p 
(aldehyde dehydrogenase) 
Guess and check 
method 
80 
Sirtinol 
 
1,600 Auxin signal increase Sirtuin 
Guess and check 
method 
81,82 
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Brassinazole 
 
Single 
compound 
BR biosynthesis 
inhibition in plant 
DWF4 
(cytochrome P450) 
Guess and check 
method 
83 
PTK787/ZK222584 
 
Single 
compound 
Block blood vessel 
formation 
VEGFR 
inhibitor 
Guess and check 
method 
84 
Tubulyzine A,B,C 
 
>100 
Delaying the epiboly 
development in zebrafish 
Tubulin 
Guess and check 
method 
85 
MP576
 
50,240 
Inhibition of 
SARS-CoV 
SARS-CoV 
M
Pro
 
Guess and check 
method 
86 
HE602 
 
50,240 
Inhibition of 
SARS-CoV 
SARS-CoV 
helicase 
Guess and check 
method 
86 
Myoseverin 
 
Single 
compound 
Fission of 
multinucleated 
myotubes into 
mononucleated 
fragments 
Tubulin 
Affinity matrix: 
biotin tag 
87,88 
Melanogenin 
 
1,170 
Pigmenting 
melanocyte 
Prohibitin 
Affinity matrix: 
on bead 
26 
Syntab A 
 
 
 
16,320 Mitosis perturbation Tubulin 
Guess and check 
method 
89 
Tubacin 
 
7,392 
Inhibits β-tubulin 
acetylation 
HDAC6 
Guess and check 
method and 
drug western 
90 
Review 
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Monastrol 
 
16,320 
Block mitosis 
endering 
Mitotic 
kinesin Eg5 
Guess and check 
method 
91 
MP C11 
 
1,536 
Induce pigmentation 
in albino murine 
melanocytes 
F1F0-ATP 
synthase 
Affinity matrix: 
on bead 
92 
ICG-001 
 
5,000 
Down regulation 
of β-catenin 
Cyclic AMP 
response 
element-binding 
protein (CBP) 
Affinity matrix: 
biotin tag 
93 
PNRI-299 
 
12 
Activator protein 1 
(AP-1) inhibitor 
Redox factor 1 (Ref-1) 
Affinity matrix: 
biotin tag 
94 
Hh-Ag 1.1 
 
140,000 Inhibition of Smo Smo 
Guess and check 
method 
95 
Wiskostatin 
 
16,320 
Prevent net 
polymerisation of actin 
Inhibits activation 
of Arp2/3 complex 
N-WASP 
Guess and check 
method 
96,97 
TWS119 
 
Not 
specified 
Induce differentiation 
of pluripotent 
EC and ES cells 
to neurons 
Glycogen 
synthase kinase-3 
(GSK-3) 
Affinity matrix: 
on bead 
22 
Ubistatin A, B 
 
 
109,113 
Inhibition of 
mitotic entry 
Ubiquitin 
Guess and check 
method 
98 
Review 
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Diminutol 
 
1,561 
Inhibitor of mitotic spindle 
assembly 
NQO1 
(an NADP-dependent 
oxidoreductase) 
Affinity matrix: 
on bead 
99 
GAPDS 
 
1,120 
Regulates DAF-2 
insulin signaling 
in C. Elegans 
GAPDH 
Affinity matrix: 
on bead 
100 
Aminopurvalanol 
 
150 
Cell cycle arrest 
at G2/M 
CDK1 
Affinity matrix: 
on bead 
87 
CGK733 
 
20,000 
Selectively block the 
ATM and ATR 
kinase checkpoint 
signaling pathway 
Ataxia 
telangiectasia mutated 
(ATM) protein 
MAGIC 
approach 
74 
BMS-790052 
 
>1million 
HCV replication 
inhibitor 
HCV NS5A 
Affinity matrix: 
biotin tag 
101 
Sulfonyl Amidine 
 
64 
Anti-resorptive 
activities to inhibit  
the osteoclastogenesis 
Prohibitin 
Affinity matrix: 
on bead 
102,103 
HUN-7293(2) 
 
Single 
molecule 
Inhibitor of vascular 
cell adhesion molecule 
(VCAM) expression 
Sec61α 
Affinity matrix: 
photoaffinity 
55 
QS11 
 
100,000 
Synergizes with 
Wnt-3a ligand  
in the activation 
of Wnt/catenin signal  
transduction and inhibits 
ARFGAP1 
ARFGAP1 
Affinity matrix: 
on bead 
104 
Quinostatin 
 
20,000 
Antagonist of 
mTOR signaling 
Class Ia PI3Ks 
Affinity matrix: 
on bead 
36 
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Pladienolide 
 
Single 
molecule 
Antitumor agent SF3b 
3H-labeled, 
fluorescence-tagged 
and photoaffinity/Biot
in (PB)-tagged 
52 
SC1 
 
 
50,000 
Self-renewal of 
ES cells 
ERK1- and RasGAP 
Affinity matrix: 
on bead 
105 
Chromeceptin 
 
10,000 
Cellular attenuators 
of the IGF signals, 
through activation  
of STAT6 
MFP-2 
Affinity matrix: 
biotin tag 
66,106 
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